Capstan Therapeutics scientists demonstrate that lipid nanoparticles can engineer CAR T cells within the body without laboratory cell manufacturing and ex vivo expansion.

Genprex's oncology program utilizes its systemic, non-viral Oncoprex ® Delivery System which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form.